Search

Unlocking Access to Lung Cancer Screening

Strategies for Improving Screening Implementation

Time zone 1: Nov 19, 2024 | 19:00-20:00 (CET) / 13:00-14:00 (EST)
Time zone 2: Nov 25, 2024 | 17:00-18:00 (SGT) / 20:00-21:00 (AEDT)

Missed our exciting webinar? The on-demand recording is now available!

Subscribe to watch the full video

Summary

Lung cancer screening (LCS) is at a turning point with more countries starting to adopt it as a national program. As screening expands, barriers at the patient, provider, and system levels have become apparent, hindering access and affecting implementation. Key challenges include the stigma of lung cancer as a self- inflicted condition, the remoteness of screening sites, varying epidemiological conditions and resources across countries, and the inefficient integration of CT screening policies at the national level.

Despite the existing knowledge about LCS, there is still much to learn about how these barriers are interconnected and how the perspectives of different key stakeholders— such as physicians, radiologists, surgeons, other healthcare staff, and potential participants— may impact various aspects of implementation, particularly in terms of access and uptake. This webinar will highlight barriers to LCS from an access perspective. Experts from various fields will come together to share strategies, insights, and best practices for improving quality and consistency of implementation, to overcome limited uptake of LCS. Additionally, they will discuss how LCS may evolve to help more people in need to have access to the screening in the future.

Learning objectives

  1. Learn about the LCS implementation in different regions.
  2. Identify key factors necessary for running successful screening programs including ensuring equitable access.
  3. Obtain insights from various countries and explore strategies to improve screening uptake and access.
  4. Learn about the role of resources such as AI and mobile units in expanding access, particularly in rural areas.

Join us for a roundtable discussion with leading clinical experts to explore how LCS implementation and uptake among eligible patients can be improved.

Prof. Ruth C. Carlos,
MD, MS

Professor of Radiology and Director of Research in Outcomes and Care Delivery Columbia University
New York, New York, USA

Prof. Marie- Pierre Revel, PhD

Professor of Radiology,
Université de Paris Head of the Radiology Department,
Cochin Hospital,
Paris, France

Prof. Kyle Chapman,
MD

Medical Director,
West Virginia University (WVU) Cancer Institute’s Mobile Cancer Screening Program
Associate Professor of Medicine, J.W. Ruby Memorial Hospital, WVU Medicine, Morgantown, West Virginia, USA

Prof. Ricardo Sales dos Santos, MD, PhD

Professor, SENAI CIMATEC University Center, Salvador, Bahia, Brazil
Thoracic Surgeon, Hospital Albert Einstein, Thoracic team at Oncoclinicas, MaterDei, HapNDI and ISG Health Networks, São Paulo, Brazil

For more information on speakers

Perspectives webinar: AI: A catalyst or inhibitor for health equity in Radiology?

Image

You might also be interested in

For more information on lung cancer screening solutions, please visit here.

Disclaimers

  • The opinions expressed in this material are solely those of the presenter and not necessarily those of Canon Medical Systems. Canon Medical Systems does not guarantee the accuracy or reliability of the information provided herein.
  • The clinical results, performance and views described in this video/webinar are the experience of the clinician. Results may vary due to clinical setting, patient presentation and other factors. Many factors could cause the actual results and performance of Canon Medical’s products to be materially different from any of the aforementioned.
  • Some products shown might not be available in all regulatory jurisdictions, please consult with your local Canon sales office for availability in your region.